At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of Resveratrol to Decrease Secondary Brain Injury Following Sports-Related Concussions: a Double-Blind, Placebo-Controlled Study
In Brief
A Phase 2 clinical trial evaluating Resveratrol and Placebo for Sports Concussion. Completed, enrolled 12 participants across 1 site.
Detailed Summary
Sports-related concussions are a serious problem in football, boxing, and other full contact sports. After experiencing consecutive concussions, there is an increase in neurological deficits that can lead to long-term cognitive problems (Dementia pugilistica). To combat this increase in brain damage, novel strategies need to be developed to protect athletes that are participating in these full contact sports. The purpose of this study is to elucidate whether resveratrol decreases brain injury and improves brain function after experiencing a concussion in boxers.
Study Details
Timeline
Interventions
The dose of resveratrol is 500 mg. The route of administration is oral, once-a-day for 30 days after injury.
The placebo is a sugar pill. The route of administration is oral, once-a-day for 30 days after injury.